invaliddata
Joined 15 years ago
Joined 15 years ago
I had a friend's dad who was one of the few people I talked to who, as a Japanese brand enthusiast, went out of his way to find a Chevy/Geo prizm - same mechanical bits as a Corolla, built in the same factory, but way cheaper because of all the people who reflexively avoided American brands.
I applaud the author and although I'm not in a position to hire anyone, I'd be more likely to hire him (ceteres paribus) because he's put this out there.
http://www.lancet.com/journals/laninf/article/PIIS1473-3099(...
(see cached version for the full text, standard link has full text behind paywall)
... China is the world's largest poultry and pig producer, and in 2014 produced 17·5 million tonnes and 56·7 million tonnes, respectively.25 Most of the production is for domestic consumption with about 10% for export.26 The global market value of veterinary drugs increased from US$8·7 billion in 1992 to $20·1 billion in 2010, and in 2018 is anticipated to reach $43 billion.27, 28, 29 China is also one of the world's highest users of colistin in agriculture.29 Driven largely by China, the global demand for colistin in agriculture is expected to reach 11 942 tonnes per annum by the end of 2015 (with associated revenues of $229·5 million), rising to 16 500 tonnes by the year 2021, at an average annual growth rate of 4·75%.29 Of the top ten largest producers of colistin for veterinary use, one is Indian, one is Danish, and eight are Chinese. Asia (including China) makes up 73·1% of colistin production with 28·7% for export including to Europe.29 In 2015, the European Union and North America imported 480 tonnes and 700 tonnes, respectively, of colistin from China.29
Some of these articles are several years old, and from sources I'd classify as more internal than foreign. It is likely that these figures would be conservative.
If this data is approximately correct, I think we could say that 1) China has an outsized effect on the problem of antibiotic resistance (even considering it's large population). 2) The US problem of antibiotic use is mostly an agricultural one (which deserves a lot of attention), and the Chinese overuse of antibiotics is not confined to either human or agricultural use.
I'm sure the chinese leadership is aware of the issue, and given their ability to make changes when something is very important (ie, air pollution during high profile events), the fact that little has been done is telling. It is likely that this simply isn't a high priority issue and thus we are unlikely to see any movement on it anytime soon.
http://china.org.cn/china/2015-07/14/content_36057168.htm http://news.xinhuanet.com/english/2015-07/14/c_134411007.htm http://content.time.com/time/world/article/0,8599,2103733,00...
For fresh grads there is almost no negotiating room on compensation. Additionally, what one learns and experiences is critical to career growth. At one sv bigco I got paid intern level wages to manually label machines in a server room for a month (hired as a developer). I'm sure this is not represent tative of that company. At another bigco I have seen fresh grads and interns get plum work assignments (and pretty good compensation, according to surveys), and I know that's not the case for many other parts of that company. Neither of these companies is appamagoogsoftbookflix, but I know both these scenarios can be found pretty much anywhere.
Even midcareer professionals should care a great deal about the people and projects they will be working with, but there the ability and need to optimize compensation can be more acute. So, avoiding optimizing for compensation and company prestige early in ones career is something to be cognizant of.